Metrics to compare | BFBI | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipBFBIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 18.3x | 18.3x | −0.3x | |
PEG Ratio | 0.61 | 0.64 | 0.00 | |
Price/Book | 2.2x | 2.8x | 2.6x | |
Price / LTM Sales | 1.2x | 1.5x | 2.9x | |
Upside (Analyst Target) | - | 25.4% | 64.3% | |
Fair Value Upside | Unlock | 19.6% | 10.0% | Unlock |
BF Biosciences Limited, a biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products in Pakistan, Nepal, Cambodia, Uzbekistan, Kenya, Afghanistan, Mauritania, Switzerland, Sri Lanka, and internationally. The company offers pharmaceutical products for various therapeutic areas, including cardiometabolic, diabetes and anti-obesity, cardiology, urology and nephrology, gastroenterology and liver, anti-fungal, oncology, anti-viral, hepatology, orthopedic, dermatology, and antibiotics. It also provides specialized injectables in vials, ampoules, cartridges, and pre-filled syringes forms. In addition, the company is involved in the sale of medical devices; and toll manufacturing services. It exports its products. The company was incorporated in 2006 and is headquartered in Lahore, Pakistan. BF Biosciences Limited operates as a subsidiary of Ferozsons Laboratories Limited.